LEHI, Utah, Dec. 8, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company, today presented new clinical data from its Phase 2a study of ofirnoflast (HT-6184) at the 67th ...
LEHI, Utah, March 11, 2025 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for chronic inflammation and obesity-related diseases, announced ...
SINGAPORE – The Halia at Singapore Botanic Gardens announced on Jan 8 that it will be ceasing operations after 25 years. In an Instagram post that day, the restaurant said it would close in mid-March ...
Halia Therapeutics has completed the enrolment in its Phase IIa trial of HT-6184 (Ofirnoflast) in those with lower-risk myelodysplastic syndrome (MDS). The two-stage trial is designed to test the ...
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company ...
The biotech won the award for its work in obesity and inflammation treatment. The Novo Nordisk Golden Ticket–Biolabs European Award is presented to a biotech company that is advancing promising work ...
Fusion restaurant Halia at the Singapore Botanic Gardens is now officially Halal-certified. The iconic restaurant nestled within the UNESCO World Heritage Site received its Halal certification from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results